Theravance Biopharma Inc (TBPH)
EBITDA Margin
4.05%
Quarterly · Period ending:
TBPH EBITDA Margin
Latest reported4.05%period ending
Latest reported4.05%period ending
TBPH Quarterly EBITDA Margin (0.00% → 4.05%)
Quarterly ebitda margin
High-resolution chart · PNG
TBPH ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 4.0471% | |
| -31.838% | |
| 163.775% | |
| -8.4042% | |
| 285.5354% | |
| -80.8617% | |
| -40.53% | |
| -50.4683% | |
| -82.5968% | |
| -59.2567% | |
| -29.4905% | |
| -35.9077% | |
| -102.0438% | |
| -214.6491% | |
| -79.7119% | |
| -95.7835% | |
| -164.5882% | |
| -201.3944% | |
| -236.8928% | |
| -373.162% | |
| -295.47% | |
| -572.3434% | |
| -402.3438% | |
| -328.6027% | |
| -327.8385% | |
| -355.5533% | |
| -191.2404% | |
| -434.5055% | |
| -115.5717% | |
| -1,179.6366% | |
| -308.2735% | |
| -446.6194% | |
| -190.3263% | |
| -744.1519% | |
| -1,700.5316% | |
| -1,471.883% | |
| -1,787.4038% | |
| -1,837.253% | |
| -1,008.4856% | |
| -169.6409% | |
| -859.8611% | |
| -222.3954% | |
| -1,414.7701% | |
| -396.1021% | |
| -626.5489% | |
| -182.1038% | |
| -4,533.9846% | |
| -773.1534% | |
| -1,883.6584% | |
| -6,273.6508% | |
| -24,792% | |
| -168,837.5% | |
| -765,060% | |
| -143,050% | |
| -635.3887% | |
| 0% |